Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
US-2024376471-A1 · Nov 14, 2024 · US
US9388459B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9388459-B2 |
| Application number | US-61494806-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 21, 2006 |
| Priority date | Jun 17, 2002 |
| Publication date | Jul 12, 2016 |
| Grant date | Jul 12, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides for methods for discriminating between alleles at polymorphic positions in a genome. In general the methods employ allele specific extension of oligonucleotides that are complementary to one of the alleles at the 3′ end of the oligonucleotide. The allele specific oligonucleotides are resistant to proof reading activity from a polymerase and may be extended in an allele specific manner by a DNA polymerase with a functional 3′ to 5′ exonuclease activity. The allele specific oligonucleotides may be attached to a solid support such as a chip or a bead.
Opening claim text (preview).
I claim: 1. A method for genotyping a plurality of polymorphisms in a nucleic acid sample, where each polymorphism has a first and a second allele, comprising: amplifying the nucleic acid sample using random primers and DNA polymerase in an isothermal amplification reaction to obtain an amplified nucleic acid sample; fragmenting the amplified nucleic acid sample to obtain a fragmented amplified nucleic acid sample; incubating the fragmented, amplified nucleic acid sample with a plurality of beads attached to allele-specific capture probes to allow formation of complexes between target fragments in the fragmented, amplified nucleic acid sample and allele-specific capture probes, wherein the plurality of beads are attached to a collection of allele-specific capture probes comprising at least 5,000different allele-specific capture probes, wherein the allele-specific capture probes comprise: (i) a linker, (ii) a cleavage region, (iii) a tag region, wherein each different allele-specific capture probe has a different sequence tag region and wherein the tag region is at least 15 bases; and, (iv) a target-specific region that terminates at its 3′ end with a base that is complementary to a polymorphic base in the target, wherein each different allele-specific capture probe has a different target-specific region; extending the allele-specific capture probes in the presence of labeled nucleotides using the target fragment as template to obtain labeled allele-specific capture probes, wherein extension of the allele-specific capture probes is blocked if there is a mismatch between the polymorphic position and the 3′ end of the allele-specific capture probe; separating the target fragment from the extended labeled allele-specific capture probes; cleaving the extended labeled allele-specific capture probes from the beads to produce released extended labeled allele-specific capture probes; detecting the released extended labeled allele-specific capture probes by hybridization to an array of tag probes of known sequence, wherein no amplification of the released extended labeled allele-specific capture probes occurs between the cleaving and detecting steps, wherein said tag probes are present at known or determinable locations on said array and each tag probe is complementary to a different tag region present in the allele-specific capture probes; and determining the genotype of said plurality of polymorphisms by determining which alleles are present, wherein the presence of hybridized labeled allele-specific capture probes is indicative of the presence of a particular allele in the nucleic acid sample. 2. The method of claim 1 wherein said step of cleaving comprises an enzymatic step. 3. The method of claim 2 wherein the cleavage region comprises one or more uracil bases and cleavage comprises incubation with uracil DNA glycosylase to generate abasic sites and the abasic sites are cleaved with an AP endonuclease or with acid or heat treatment. 4. The method of claim 2 wherein the cleavage region comprises one or more inosines and cleavage comprises incubation with Endonuclease V. 5. The method of claim 1 wherein said step of cleaving comprises photocleavage of a light-sensitive linkage in a capture probe. 6. A method for genotyping a plurality of polymorphisms in a nucleic acid sample comprising: amplifying the nucleic acid sample using random primers and DNA polymerase in an isothermal amplification reaction to obtain an amplified nucleic acid sample; fragmenting the amplified nucleic acid sample to generate target fragments; hybridizing a collection of capture probes comprising at least 5,000 different capture probes, to target fragments, wherein said capture probes are attached to a solid support at a 5′ end and each comprises: (i) a spacer sequence near said 5′ end, (ii) a dU region comprising a plurality of uracil residues, (iii) a tag sequence of at least 15 bases that is unique for each species of capture probe, (iv) a target-specific sequence, and (v) an allele-specific nucleotide corresponding to one allele of a polymorphism in said plurality of polymorphisms, wherein the capture probes terminate at their 3′ end with said allele-specific nucleotide; extending said capture probes with a DNA polymerase to generate extended capture probes in an allele-specific extension reaction; washing the solid support to remove the target fragments; cleaving the extended capture probes from the solid support by a method comprising photocleavage or enzymatic cleavage to produce released extended capture probes; detecting the released extended capture probes by hybridization to an array comprising a plurality of tag probe features, wherein no amplification of the released extended allele-specific capture probes occurs between the cleaving and detecting steps, wherein each tag probe feature comprises a different tag probe and wherein said tag probes are complementary to the tag sequences of the capture probes; and determining the genotype of said plurality of polymorphisms by determining which alleles are present, wherein the presence of hybridized allele-specific capture probes is indicative of the presence of a particular allele in the nucleic acid sample. 7. The method of claim 6 wherein the solid support comprises a plurality of beads. 8. The method of claim 7 wherein the beads are coated with anti-digoxidenin, and the capture probes comprise a digoxigenin label. 9. The method of claim 6 wherein the capture probes are exonuclease-resistant at the 3′ end and the DNA polymerase used to generate the extended capture probes has 3′ to 5′ exonuclease proofreading activity. 10. The method of claim 9 wherein the DNA polymerase is selected from the group consisting of T4 DNA polymerase, E. coli Klenow fragment, and T7 DNA polymerase. 11. The method of claim 6 wherein the cleavage from the solid support is enzymatic and comprises cleavage with an endonuclease. 12. The method of claim 6 wherein the cleavage from the solid support is enzymatic and comprises treatment with uracil DNA glycosylase and heat or acid treatment. 13. The method of claim 6 , wherein the cleavage from the solid support is photocleavage and comprises exposure to UV light with a wavelength between 200 and 400 nanometers. 14. The method of claim 6 wherein the dU region comprises a plurality of inosine residues and the cleavage step comprises cleavage with Endonuclease V. 15. The method of claim 14 wherein the dU region comprises UIUI. 16. The method of claim 6 wherein the 3′ end of the capture probes comprises 0, 1, or 3 phosphorothioate linkages.
PCR · CPC title
characterised by the capture oligonucleotide acting as a primer · CPC title
characterised by the use of the arrayed oligonucleotides as identifier tags, e.g. universal addressable array, anti-tag or tag complement array · CPC title
incorporating/generating a new priming site · CPC title
Polymerase chain reaction [PCR] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.